AU1772699A - Succinimide derivatives which inhibit retinoic acid metabolism - Google Patents

Succinimide derivatives which inhibit retinoic acid metabolism

Info

Publication number
AU1772699A
AU1772699A AU17726/99A AU1772699A AU1772699A AU 1772699 A AU1772699 A AU 1772699A AU 17726/99 A AU17726/99 A AU 17726/99A AU 1772699 A AU1772699 A AU 1772699A AU 1772699 A AU1772699 A AU 1772699A
Authority
AU
Australia
Prior art keywords
retinoic acid
acid metabolism
succinimide derivatives
inhibit retinoic
inhibit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17726/99A
Inventor
Masoud Ahmadi
Paul Joseph Nicholls
Harold John Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College Cardiff Consultants Ltd
Original Assignee
University College Cardiff Consultants Ltd
Cardiff University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College Cardiff Consultants Ltd, Cardiff University filed Critical University College Cardiff Consultants Ltd
Publication of AU1772699A publication Critical patent/AU1772699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C07D207/408—Radicals containing only hydrogen and carbon atoms attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU17726/99A 1998-01-02 1998-12-21 Succinimide derivatives which inhibit retinoic acid metabolism Abandoned AU1772699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9800040 1998-01-02
GBGB9800040.9A GB9800040D0 (en) 1998-01-02 1998-01-02 Pyrrolidine dione derivatives
PCT/GB1998/003869 WO1999035129A1 (en) 1998-01-02 1998-12-21 Succinimide derivatives which inhibit retinoic acid metabolism

Publications (1)

Publication Number Publication Date
AU1772699A true AU1772699A (en) 1999-07-26

Family

ID=10824771

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17726/99A Abandoned AU1772699A (en) 1998-01-02 1998-12-21 Succinimide derivatives which inhibit retinoic acid metabolism

Country Status (4)

Country Link
AU (1) AU1772699A (en)
GB (1) GB9800040D0 (en)
WO (1) WO1999035129A1 (en)
ZA (1) ZA9811937B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003671D0 (en) * 2000-02-17 2000-04-05 Univ Cardiff Diphenyl-substituted lower alkanes
GB0020351D0 (en) * 2000-08-17 2000-10-04 Catalyst Biomedica Ltd Treatment of hyperproliferative diseases
GB0029524D0 (en) * 2000-12-04 2001-01-17 Univ Sheffield Disease treatment
JPWO2021049255A1 (en) * 2019-09-09 2021-03-18

Also Published As

Publication number Publication date
GB9800040D0 (en) 1998-03-04
WO1999035129A1 (en) 1999-07-15
ZA9811937B (en) 1999-07-19

Similar Documents

Publication Publication Date Title
AU1095799A (en) Folic acid derivatives
AU6238900A (en) Small library horseshoe architecture
AU4580599A (en) Stable no-delivering compounds
AU6972398A (en) Phosphonic acid derivatives
IL139470A0 (en) Oxyiminoalkanoic acid derivatives
IL140358A0 (en) Aminomethylarboxylic acid derivatives
AU6148099A (en) Power supplyer for amplifiers
AU5391199A (en) Self-tanning towelette
AU1559199A (en) Isothiazolcarboxylic acid derivatives
AU1268400A (en) Isothiazolecarboxylic acid derivatives
AU1303201A (en) Alkoxyiminoalkanoic acid derivatives
AU3791899A (en) (2-acylaminothiazole-4-yl)acetic acid derivatives
AU5345798A (en) Fructan-polycarboxylic acid
AU1772699A (en) Succinimide derivatives which inhibit retinoic acid metabolism
AU4922399A (en) Bicyclohexane derivatives
AU4547896A (en) 4-oxo-2-butenoic acid derivatives
AU4215599A (en) Dermatological compounds
AU5289299A (en) Divinylstilbenesulfonic acid derivatives
AU3332199A (en) Phenyl-methoxyimino-glyoxylic acid derivatives as pesticides
AU5232399A (en) Sulfur metabolism enzymes
AU5191199A (en) Fatty acid derivatives
AU1608499A (en) Zwitterionic fatty acid compounds for anti-inflamation
AU2690600A (en) 2-mercaptocarboxylic acid derivatives
AU3953899A (en) Cyclooxygenase-2 inhibitors
AU1916797A (en) Anti-viral 4-acylamino-3-{imidazol-i-yl}-benzoic acid derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase